CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) [Phase 2]

A Phase 2 trial evaluated the efficacy and safety of SAF312 eye drops for post-operative corneal induced chronic pain; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Ocular Pain | Phase 2 | Status: COMPLETED | Results posted: 2024-04-18